I Peace, Inc. ( specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the next generation iPS cell mass-manufacturing automated system (EGG) the ...

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with ...

The trial builds upon over ten years of collaborative research and paves the way for future multi-centre trials led by ...

A research team led by Kyoto University said Wednesday it has prevented kidney functions from declining in mice using human ...

Japan is a global leader in cutting-edge research into the use of iPS cells, whose potentials include the development of revolutionary new medicines and treatments for incurable diseases. We sat down ...

The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...

Induced pluripotent stem cells, or iPS cells for short, were first achieved by a team at Kyoto University’s Institute for Frontier Medical Sciences in 2006. Yamanaka Shin’ya, one of the lead ...

KYOTO—Researchers have safely transplanted nerve cells generated from induced pluripotent stem (iPS) cells into the brains of ...

Keio University researchers used induced pluripotent stem cells (iPS cells) created by stimulating mature, specialized cell ...

If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean ...

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...